Mair Therapeutics

Mair Therapeutics

This biotechnology company develops small-molecule therapies targeting lysosomal ion channels to treat neurodegenerative disorders such as Parkinson's disease for patients and healthcare institutions.

Lysosomal Therapeutics

This biotechnology firm develops small-molecule therapies for patients with neurodegenerative conditions such as Parkinson's disease and other lysosomal storage disorders.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

NRG Therapeutics

This neuroscience company develops small molecule medicines targeting mitochondrial dysfunction to treat patients with Parkinson's and amyotrophic lateral sclerosis.

Yumanity Therapeutics

This company develops small molecule drugs to treat neurodegenerative diseases for patients with conditions such as Parkinson's disease and amyotrophic lateral sclerosis.

Pano Therapeautics

This biotechnology company develops small molecule drugs targeting mitochondrial ion channels to treat neurodevelopmental disorders and complex diseases of aging.

Polku Therapeutics

This company develops small-molecule drugs to treat neurodegenerative disorders such as Parkinson's and Alzheimer's disease for patients and pharmaceutical partners.

Violet Therapeutics

This company develops small molecule inhibitors for pharmaceutical researchers to treat neurodegenerative diseases, including Alzheimer’s and Parkinson’s.